Follow Us

The Latest

Promo Image

Patient/Doctor Q&A With Patrick McNamara, M.D.

Patrick McNamara, M.D., answers questions about starting meds, controlling diarrhea and a new approach to treating facial wasting.

Q: I am a 27-year-old male who just tested HIV positive last March. My T cells are 345 now (down from 372 in March) an...

Promo Image

Patient/Doctor Q&A

Q: I began taking d4T and 3TC in 1996 with a viral load of almost 30,000 and a T-cell count of about 380. The drugs kept my viral load undetectable and my T-cell count as high as 950. However, I got off drugs one year ago when signs of peripheral neu...

Promo Image

Medication Vacations

From the ever-evolving world of HIV vocabulary comes a new phrase that has been given much press recently: Structured Treatment Interruption (STI). Although it sounds more like a military maneuver, STI simply means taking a brief vacation from your H...

Promo Image

AIDS Practice Issues Today

Paul Bellman, M.D., and his associate, Ricky Hsu, M.D., are in private practice in Manhattan. We asked Dr. Bellman about drug toxicity, treatment interruption, and other major issues he is seeing today in HIV/AIDS clinical care.

AIDS Treatment News:...

Promo Image

Treatment Models From India

Shashank R. Joshi, M.D., president of the HOPE Foundation in Mumbai, India, is an HIV specialist in a public hospital system with more than 36,000 patients with HIV; in addition, he follows over 500 HIV patients in his private practice, and more than...

Promo Image

HAART and Medical Management: The Realities of Clinic Care

At the recent Retroviruses conference (January 30 - February 2 in San Francisco), Dr. Keith Henry told us about his upcoming article, "The Case for More Cautious, Patient-Focused Antiretroviral Therapy," which was published in the February 15 Annals ...

Promo Image

Adherence and Double Therapies: An Interview With Charles Farthing, M.D.

"I do not believe that the first regimen should be designed to be salvaged. I know that a great number of AIDS physicians support this, but once the first regimen has failed, a patient's chance of doing better on the second regimen is not increased."...